Cargando…

Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors

OBJECTIVE: To test the hypothesis that extracorporeal therapy with polymyxin B (PMX-B) may prevent Gram-negative sepsis-induced acute renal failure (ARF) by reducing the activity of proapoptotic circulating factors. SETTING: Medical-Surgical Intensive Care Units. PATIENTS AND INTERVENTIONS: Sixteen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cantaluppi, Vincenzo, Assenzio, Barbara, Pasero, Daniela, Romanazzi, Giuseppe Mauriello, Pacitti, Alfonso, Lanfranco, Giacomo, Puntorieri, Valeria, Martin, Erica L., Mascia, Luciana, Monti, Gianpaola, Casella, Giampaolo, Segoloni, Giuseppe Paolo, Camussi, Giovanni, Ranieri, V. Marco
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2008
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2517091/ https://www.ncbi.nlm.nih.gov/pubmed/18463848 http://dx.doi.org/10.1007/s00134-008-1124-6

Ejemplares similares

Regional citrate-calcium anticoagulation during polymyxin-B hemoperfusion: A case series
por: Forfori, Francesco, et al.
Publicado: (2018)

Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2016)

Circulating plasma factors induce tubular and glomerular alterations in septic burns patients
por: Mariano, Filippo, et al.
Publicado: (2008)

Polymyxin B hemoperfusion in high endotoxin activity level septic shock patients
por: Monti, G, et al.
Publicado: (2008)

Polymyxin B hemoperfusion: a mechanistic perspective
por: Ronco, Claudio, et al.
Publicado: (2014)

More effective use of polymyxin-B hemoperfusion for nonoperation cases
por: Yahata, M, et al.
Publicado: (2014)

Effective use of polymyxin B hemoperfusion in septic shock complicated by urosepsis
por: Malleshappa, P., et al.
Publicado: (2011)

Polymyxin B-direct hemoperfusion therapy contributes to oxygen delivery in septic patients
por: Yaguchi, A, et al.
Publicado: (2012)

Polymyxin B-immobilized fiber hemoperfusion therapy improves sepsis-related immunosuppression
por: Kimura, A, et al.
Publicado: (2014)

Polymyxin B-direct hemoperfusion therapy improves mean arterial pressure in septic shock
por: Yokota, Mari, et al.
Publicado: (2013)

Beneficial effects of early hemoperfusion with a polymyxin B fibre column on septic shock
por: Takeyama, N, et al.
Publicado: (2009)

Efficacy of direct hemoperfusion with a polymyxin B‐immobilized fiber column in miliary tuberculosis
por: Kawano, Yasumasa, et al.
Publicado: (2016)

Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
por: Honore, Patrick M., et al.
Publicado: (2018)

Effectiveness of polymyxin B hemoperfusion in acute exacerbation of interstitial pneumonia: a retrospective analysis
por: Lee, Song-I
Publicado: (2021)

Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19
por: Katagiri, Daisuke, et al.
Publicado: (2020)

Polymyxin B Hemoperfusion in Pediatric Septic Shock: Single-Center Observational Case Series
por: Saetang, Patcharin, et al.
Publicado: (2022)

Polymyxin B-direct hemoperfusion therapy could contribute to hemodynamics and outcomes in emergency surgical patients
por: Yokota, M, et al.
Publicado: (2012)

Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
por: Matsuo, SM, et al.
Publicado: (2011)

Endotoxin activity assay and polymyxin B hemoperfusion use in a cohort of critically ill patients
por: Cutuli, SL, et al.
Publicado: (2014)

Oxygen metabolism as an indicator in criteria for hemoperfusion using a polymyxin-B immobilized column introduction
por: Kushi, H, et al.
Publicado: (2005)

The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients
por: Srisawat, Nattachai, et al.
Publicado: (2018)

Suggestions and tips regarding polymyxin B-immobilized fiber column direct hemoperfusion of neonates with sepsis
por: Nishizaki, Naoto
Publicado: (2020)

The golden hour of polymyxin B hemoperfusion in endotoxic shock: The basis for sequential extracorporeal therapy in sepsis
por: De Rosa, Silvia, et al.
Publicado: (2019)

Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock
por: Kim, Jin Joo, et al.
Publicado: (2019)

Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock
por: Mitaka, Chieko, et al.
Publicado: (2021)

Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
por: Kushi, Hidehiko, et al.
Publicado: (2005)

Polymyxin B-immobilized fiber column hemoperfusion has the ability of endotoxin removal during 24 hours
por: Mitaka, C, et al.
Publicado: (2012)

Catecholamine index is a simple and useful marker for bacteremic patients treated by polymyxin B hemoperfusion therapy
por: Isa, Y, et al.
Publicado: (2011)

Hemoperfusion with an immobilized polymyxin B fiber column improves gastric mucosal pH with sepsis patients
por: Kushi, H, et al.
Publicado: (2006)

Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock: a case–control study
por: Navas, Ana, et al.
Publicado: (2018)

Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study
por: Fujimori, Kenji, et al.
Publicado: (2021)

The effects of direct hemoperfusion with polymyxin B-immobilized fiber in patients with acute exacerbation of interstitial lung disease
por: Lee, Jae Ha, et al.
Publicado: (2021)

Changes in Oxygenation and Serological Markers in Acute Exacerbation of Interstitial Lung Disease Treated with Polymyxin B Hemoperfusion
por: Lee, Song-I, et al.
Publicado: (2022)

Modifications of peripheral perfusion in patients with vasopressor-dependent septic shock treated with polymyxin B-direct hemoperfusion
por: Sekino, Motohiro, et al.
Publicado: (2023)

278. Effects of polymyxin B direct hemoperfusion by measurement of outer membrane vesicles in patients with septic shock
por: Min Jo, Kyeong
Publicado: (2023)

Extended duration of direct hemoperfusion with polymyxin B-immobilized fiber column improves hemodynamics in patients with septic shock
por: Yamashita, C, et al.
Publicado: (2011)

Early introduction of hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
por: Kushi, H, et al.
Publicado: (2005)

Effect of Hemoperfusion Using Polymyxin B-immobilized Fibers on Acute Lung Injury in a Rat Sepsis Model
por: Iba, Toshiaki, et al.
Publicado: (2014)

Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study
por: Nakamura, Yoshihiko, et al.
Publicado: (2017)

Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection
por: Saito, Nobuyuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t83vk79k03eq9j8nldqk6rce08